Unconventional myosins and the regulation of gut barrier integrity and restitution during inflammation
非常规肌球蛋白以及炎症期间肠道屏障完整性和恢复的调节
基本信息
- 批准号:10443882
- 负责人:
- 金额:$ 45.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalActomyosinAcuteAddressAdherens JunctionAdhesionsAffectAirApicalBasal CellBindingBiochemicalBiological MarkersBiosensorCRISPR/Cas technologyCeliac DiseaseCell Culture TechniquesCell DeathCell Differentiation processCell LineCell PolarityCell membraneCellsChronic PhaseColitisComplexCrohn&aposs diseaseCytoskeletonDataDefectDefense MechanismsDestinationsDetergentsDevelopmentDigestive System DisordersDiseaseDisease remissionDown-RegulationEpithelialEpithelial AttachmentEpithelial CellsEventExtracellular MatrixFluorescence Resonance Energy TransferFractionationGastrointestinal DiseasesGenesGeneticGut MucosaHealthHumanImageImmunoprecipitationImpairmentIn VitroIncidenceInfectious colitisInflammationInflammatoryInflammatory Bowel DiseasesInjuryIntestinal DiseasesIntestinal MucosaIntestinal permeabilityKnock-outKnockout MiceKnowledgeLeaky GutLinkLiquid substanceMalignant NeoplasmsMeasurementMediatingMicrofilamentsMicroscopyModelingMolecularMorbidity - disease rateMorphogenesisMotorMucositisMucous MembraneMuscleMyosin ATPaseMyosin Type IINeuronsOrganoidsOutcomePathogenesisPatientsPeriodicityPermeabilityPharmacologyPhysiologyPreventionProcessPublic HealthRecoveryRegulationResolutionRoleScaffolding ProteinSignal TransductionStructureTestingTherapeutic InterventionTight JunctionsUlcerative ColitisWestern Blottingattenuationcell motilitycohortcytokinedisorder controlepithelial injuryexperimental studygut homeostasisgut inflammationhealingimprovedin vivoinjuredinnovationinsightintestinal barrierintestinal epitheliumknockout animalmonolayermortalitymotor controlmouse modelmutantnew therapeutic targetnon-muscle myosinnoveloverexpressionpathogenic bacteriapreventrepairedrestorationtargeted treatmenttumor growthwoundwound healing
项目摘要
PROJECT SUMMARY: Disruption of the intestinal epithelial barrier in patients with inflammatory bowel
diseases (IBD) involves disassembly of epithelial tight junctions (TJ) and adherens junctions (AJ), along with
formation of mucosal wounds due to excessive epithelial cell death. Restoration of the gut barrier (epithelial
restitution) is critical for achieving remission of the disease and it involves mucosal wound healing and AJ/TJ
reassembly. Both processes are mediated by common molecular events, most notably, dramatic remodeling of
the epithelial actomyosin cytoskeleton. An unconventional myosin 18A (Myo18A) is a unique PDZ-domain
containing scaffolding protein that acts as an essential regulator of actin filaments and their motor, non-muscle
myosin II (NM II). Myo18A is known to control neuronal and muscle morphogenesis, as well as tumor growth
and dissemination, however its functions in the gut have not been previously investigated. Our preliminary data
suggests that Myo18A is abundantly expressed in normal human intestinal epithelium and it is a novel
component of epithelial junctions, Furthermore, Myo18A depletion leads to various functional defects, including
disruption of the epithelial barrier, attenuation of wound healing and impairment of 3-D epithelial
morphogenesis. Importantly, we observed a marked downregulation of Myo18A expression in the intestinal
epithelium of ulcerative colitis patients. This exciting preliminary data provides a strong scientific premise for
the following innovative hypothesis: Myo18A is a novel regulator of the intestinal epithelial barrier
integrity and restitution, and its depletion promotes gut leakiness and inhibits mucosal healing in IBD
patients.
This hypothesis will be tested in the following Aims: (1) to determine the roles of Myo18A in the regulation of
intestinal epithelial cell migration and ECM adhesion; (2) to delineate the mechanisms of Myo18A-dependent
assembly of the epithelial barrier and establishment of the apico-basal cell polarity; 3) to examine the roles of
Myo18A in regulating disruption and restitution of the intestinal epithelial barrier in vivo. The Aims will be
accomplished by studies utilizing in vitro intestinal epithelial cell monolayers, ex vivo colonic organoids
generated from IBD mucosa and in vivo murine models of epithelial injury and restitution. Roles of Myo18A will
be examined by a combination of functional (permeability measurements, wound healing), biochemical
(immunoblotting, detergent fractionation), imaging (FRET biosensors, super-resolution microscopy), and
genetic (CRISPR/Cas9 gene editing, overexpression of deletion mutants, knockout mice) approaches.
Significance: the proposed study will yield novel insights into the mechanisms that regulate intestinal epithelial
injury and restitution during inflammation. It will also identify new therapeutic targets to prevent breakdown and
enhance reparation of the gut barrier in patients with digestive diseases.
项目摘要:炎症患者肠上皮屏障的破坏
疾病(IBD)涉及上皮紧密连接(TJ)和粘附连接(AJ)的拆卸,以及
由于上皮细胞死亡过多而导致的粘膜伤。修复肠道障碍(上皮
恢复原状)对于实现疾病的缓解至关重要,它涉及粘膜伤口愈合和AJ/TJ
重新组装。这两个过程均由常见分子事件介导,最值得注意的是,
上皮性肌球蛋白细胞骨架。非常规肌球蛋白18a(myo18a)是独特的PDZ域
含有脚手架蛋白,可作为肌动蛋白丝及其电动机的必不可少的调节剂
肌球蛋白II(NM II)。已知MyO18a可以控制神经元和肌肉形态发生,以及肿瘤的生长
但是,以前尚未研究其在肠道中的功能。我们的初步数据
表明Myo18a在正常的人类肠上皮中大量表达,这是一种新颖
上皮连接的组成部分,此外,Myo18a耗竭会导致各种功能缺陷,包括
上皮屏障的破坏,伤口愈合的衰减和3D上皮的损害
形态发生。重要的是,我们观察到肠道中肌18a表达的明显下调
溃疡性结肠炎患者上皮。这个令人兴奋的初步数据为科学的前提提供了强大的前提
以下创新假设:Myo18a是肠上皮屏障的新型调节剂
完整性和恢复原状及其耗竭会促进肠道泄漏,并抑制IBD中的粘膜愈合
患者。
该假设将在以下目的中进行检验:(1)确定myo18a在调节中的作用
肠上皮细胞迁移和ECM粘附; (2)描述依赖MyO18A的机制
上皮屏障的组装和Apico-Basal细胞极性的建立; 3)检查
Myo18a在体内调节肠上皮屏障的破坏和恢复。目的将是
通过使用体外肠上皮细胞单层的研究完成
由IBD粘膜和上皮损伤和恢复原状的体内鼠模型产生。 Myo18a的角色将
通过功能(渗透率测量,伤口愈合),生化的结合来检查
(免疫印迹,洗涤剂分馏),成像(FRET生物传感器,超分辨率显微镜)和
遗传(CRISPR/CAS9基因编辑,缺失突变体的过表达,敲除小鼠)方法。
意义:拟议的研究将对调节肠上皮的机制产生新的见解
炎症期间的伤害和恢复原状。它还将确定新的治疗靶标,以防止细分和
增加消化疾病患者的肠道屏障的赔偿。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inflammation modulates intercellular adhesion and mechanotransduction in human epidermis via ROCK2.
- DOI:10.1016/j.isci.2023.106195
- 发表时间:2023-03-17
- 期刊:
- 影响因子:5.8
- 作者:Shutova, Maria S.;Borowczyk, Julia;Russo, Barbara;Sellami, Sihem;Drukala, Justyna;Wolnicki, Michal;Brembilla, Nicolo C.;Kaya, Gurkan;Ivanov, Andrei I.;Boehncke, Wolf-Henning
- 通讯作者:Boehncke, Wolf-Henning
Unique and redundant functions of cytoplasmic actins and nonmuscle myosin II isoforms at epithelial junctions.
- DOI:10.1111/nyas.14808
- 发表时间:2022-09
- 期刊:
- 影响因子:5.2
- 作者:Ivanov AI;Lechuga S;Marino-Melendez A;Naydenov NG
- 通讯作者:Naydenov NG
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrei Ivanovich Ivanov其他文献
Andrei Ivanovich Ivanov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrei Ivanovich Ivanov', 18)}}的其他基金
Novel cytoskeletal mechanisms of pathogenic bacteria interactions with intestinal epithelium
病原菌与肠上皮相互作用的新细胞骨架机制
- 批准号:
10663379 - 财政年份:2022
- 资助金额:
$ 45.26万 - 项目类别:
Novel cytoskeletal mechanisms of pathogenic bacteria interactions with intestinal epithelium
病原菌与肠上皮相互作用的新细胞骨架机制
- 批准号:
10516636 - 财政年份:2022
- 资助金额:
$ 45.26万 - 项目类别:
Unconventional myosins and the regulation of gut barrier integrity and restitution during inflammation
非常规肌球蛋白以及炎症期间肠道屏障完整性和恢复的调节
- 批准号:
10261489 - 财政年份:2020
- 资助金额:
$ 45.26万 - 项目类别:
Unconventional myosins and the regulation of gut barrier integrity and restitution during inflammation
非常规肌球蛋白以及炎症期间肠道屏障完整性和恢复的调节
- 批准号:
10094455 - 财政年份:2020
- 资助金额:
$ 45.26万 - 项目类别:
Actomyosin cytoskeleton and the regulation of intestinal eipithelial barrier
肌动球蛋白细胞骨架与肠上皮屏障的调节
- 批准号:
9304208 - 财政年份:2016
- 资助金额:
$ 45.26万 - 项目类别:
Actomyosin cytoskeleton and the regulation of intestinal eipithelial barrier
肌动球蛋白细胞骨架与肠上皮屏障的调节
- 批准号:
9606158 - 财政年份:2016
- 资助金额:
$ 45.26万 - 项目类别:
Junctional exocytosis and breakdown of the intestinal barrier in inflammation
炎症中的连接胞吐作用和肠道屏障的破坏
- 批准号:
8465630 - 财政年份:2010
- 资助金额:
$ 45.26万 - 项目类别:
Junctional exocytosis and breakdown of the intestinal barrier in inflammation
炎症中的连接胞吐作用和肠道屏障的破坏
- 批准号:
8051683 - 财政年份:2010
- 资助金额:
$ 45.26万 - 项目类别:
Actin dynamics and regulation of epithelial barrier in intestinal inflammation
肠道炎症中肌动蛋白动力学和上皮屏障的调节
- 批准号:
8587379 - 财政年份:2010
- 资助金额:
$ 45.26万 - 项目类别:
相似国自然基金
由actomyosin介导的集体性细胞迁移对唇腭裂发生的影响的研究
- 批准号:82360313
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
丙酮酸激酶催化肌动球蛋白磷酸化调控肉嫩度的分子机制
- 批准号:32372263
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
鱼糜肌动球蛋白的增效转化及其氧化控制分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:59 万元
- 项目类别:面上项目
基于Pickering纳米乳液脂质诱导肌动球蛋白凝胶的空间位阻效应及其机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
基于Pickering纳米乳液脂质诱导肌动球蛋白凝胶的空间位阻效应及其机制
- 批准号:32172242
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
相似海外基金
Rac1 and the actin cytoskeleton in renal tubular repair
Rac1 和肌动蛋白细胞骨架在肾小管修复中的作用
- 批准号:
10739610 - 财政年份:2023
- 资助金额:
$ 45.26万 - 项目类别:
The role of myosin II in tendon repair under glucose control
肌球蛋白 II 在葡萄糖控制下肌腱修复中的作用
- 批准号:
10649584 - 财政年份:2022
- 资助金额:
$ 45.26万 - 项目类别:
The role of myosin II in tendon repair under glucose control
肌球蛋白 II 在葡萄糖控制下肌腱修复中的作用
- 批准号:
10440751 - 财政年份:2022
- 资助金额:
$ 45.26万 - 项目类别:
Role of AJC in umbrella cell function and dysfunction
AJC 在伞细胞功能和功能障碍中的作用
- 批准号:
10655616 - 财政年份:2021
- 资助金额:
$ 45.26万 - 项目类别:
Role of AJC in umbrella cell function and dysfunction
AJC 在伞细胞功能和功能障碍中的作用
- 批准号:
10482413 - 财政年份:2021
- 资助金额:
$ 45.26万 - 项目类别: